Vlagea A, Falagan S, Gutiérrez-Gutiérrez G, Moreno-Rubio J, Merino M, Zambrana F, et al. Antinuclear antibodies and cancer: A literature review. Crit Rev Oncol Hematol [Internet]. 2018;127:42–9. Disponible en: http://dx.doi.org/10.1016/j.critrevonc.2018.05.002
DOI: 10.1016/j.critrevonc.2018.05.002
Bhakta V. Rare Antinuclear Antibody patterns: Relevance in routine laboratory reporting. J Clin Diagn Res [Internet]. 2023; Disponible en: https://www.jcdr.net/article_abstract.asp?issn=0973-709x&year=2023&month=January&volume=17&issue=1&page=EC10-EC14&id=17321
Vermeersch P, Van den Bergh K, Blockmans D, Westhovens R, Bossuyt X. Anti-Golgi autoantibodies are not clinically associated with systemic autoimmune diseases. Ann Rheum Dis [Internet]. 2011;70(1):234–5. Disponible en: http://dx.doi.org/10.1136/ard.2009.126391
DOI: 10.1136/ard.2009.126391
Staub HL, Souza F, Chan EK, von Mühlen CA. Anti-Golgi antibodies in adult Still’s disease. Clin Exp Rheumatol [Internet]. 2003 [citado el 23 de agosto de 2024];21(2). Disponible en: https://pubmed.ncbi.nlm.nih.gov/12747298/
Stinton LM, Eystathioy T, Selak S, Chan EKL, Fritzler MJ. Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol [Internet]. 2004;110(1):30–44. Disponible en: http://dx.doi.org/10.1016/j.clim.2003.10.005
DOI: 10.1016/j.clim.2003.10.005